Latest filing published 29 May 2015 for Viveve Medical, INC., €211k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Samuel Colella: trading record in brief
Mark Samuel Colella discloses dealings in Viveve Medical, Inc. to SEC (Form 4). Between 23 September 2014 and 14 May 2015, the trades on record add up to 6 filings.
Every open-market trade on record is a purchase: 4 purchases worth €2.4M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2015 to date brings 2 purchases and no sales.
A typical purchase (the median) is worth €146k.
On 29 May 2015 came the latest disclosure, an open-market purchase for €211k in Viveve Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Samuel Colella
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 650,026 shares@ US$0.37Common StockSEC:0001437749-15-011406:0Canonical exit: 12 Aug 2015 (T+90)
- 25,649 shares@ US$0.37Common StockSEC:0001437749-15-011406:1Canonical exit: 12 Aug 2015 (T+90)
- 1,642,528 sharesCommon StockSEC:0001144204-14-057943:0
- 64,811 sharesCommon StockSEC:0001144204-14-057943:2
4 of 4 declarations